Study of Accuracy of NGAL, a Renal Injury Biomarker, in Patients With Cirrhosis
N/A
The purpose of this study is to test the accuracy of urinary neutrophil-gel...
Status
Unknown
Location
Federal University of Espirito Santo
Start Date
2013-06
Trial ID
NCT02049125
We Collected Blood Samples From Septic Shock Patients and Measured ELABELA, Creatinine, and NGAL Levels. Survival After 7 Days Was Recorded and Analyzed to Evaluate the Potential of Serum ELABELA as an Early Diagnostic Marker for Sepsis-associated Acute Kidney Injury.
N/A
The investigators selected patients diagnosed with sepsis who were admitted...
Status
Unknown
Location
Department of Critical Care Medicine, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University
Start Date
2022-07-03
Trial ID
NCT06001294
Biomarkers of Renal Dysfunction in Neuroblastoma Survivors
N/A
The main purpose of this study is to learn more about biomarkers of kidney ...